Akshay Anil Binayke

Mr. Akshay Anil Binayke

Translational Health Science and Technology Institute, Gurgaon, India
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in eLife
Verified
Journal Article
Open access
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
RDRajdeep Dalal
Rajdeep Dalal
SSSrikanth Sadhu
Srikanth Sadhu
ABAkshay Anil Binayke
Akshay Anil Binayke
JDJyotsna Dandotiya
Jyotsna Dandotiya
AAAmit Awasthi
Amit Awasthi
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Here, we show, using a hamster model, that the early phase of SARS-CoV-2 infection leads to an acute inflammatory response and lung pathologies, while the late phase of infection causes cardiovascular complications (CVCs) characterized by ventricular wall thickening associated with increased ventricular mass/body mass ratio and interstitial coronary fibrosis. Molecular profiling further substantiated our findings of CVC as SARS-CoV-2-infected hamsters showed elevated levels of serum cardiac troponin I, cholesterol, low-density lipoprotein, and long-chain fatty acid triglycerides. Serum metabolomics profiling of SARS-CoV-2-infected hamsters identified N-acetylneuraminate, a functional metabolite found to be associated with CVC, as a metabolic marker was found to be common between SARS-CoV-2-infected hamsters and COVID-19 patients. Together, we propose hamsters as a suitable animal model to study post-COVID sequelae associated with CVC, which could be extended to therapeutic interventions.

2 January 2024 in npj Vaccines
Verified
Journal Article
Open access
PDF file
ABAkshay Anil Binayke
Akshay Anil Binayke
AZAymaan Zaheer
Aymaan Zaheer
SVSiddhesh Vishwakarma
Siddhesh Vishwakarma
SSSavita Singh
Savita Singh
PSPriyanka Sharma
Priyanka Sharma
AAAmit Awasthi
Amit Awasthi
Measuring SARS-CoV-2-specific T cell responses is crucial to understanding an individual’s immunity to COVID-19. However, high inter- and intra-assay variability make it difficult to define T cells as a correlate of protection against COVID-19. To address this, we performed systematic review and meta-analysis of 495 datasets from 94 original articles evaluating SARS-CoV-2-specific T cell responses using three assays – Activation Induced Marker (AIM), Intracellular Cytokine Staining (ICS), and Enzyme-Linked Immunospot (ELISPOT), and defined each assay’s quantitative range. We validated these ranges using samples from 193 SARS-CoV-2-exposed individuals. Although IFNγ ELISPOT was the preferred assay, our experimental validation suggested that it under-represented the SARS-CoV-2-specific T cell repertoire. Our data indicate that a combination of AIM and ICS or FluoroSpot assay would better represent the frequency, polyfunctionality, and compartmentalization of the antigen-specific T cell responses. Taken together, our results contribute to defining the ranges of antigen-specific T cell assays and propose a choice of assay that can be employed to better understand the cellular immune response against viral diseases.

4 August 2025 in European Journal of Immunology
Verified
Journal Article
Closed access
ABAkshay Anil Binayke
Akshay Anil Binayke
RDRajdeep Dalal
Rajdeep Dalal
CSCharu Suri
Charu Suri
JDJyotsna Dandotiya
Jyotsna Dandotiya
SSSrikanth Sadhu
Srikanth Sadhu
AAAmit Awasthi
Amit Awasthi

15 May 2023 in EMBO Reports
Verified
Journal Article
Closed access
SAShabnam Ansari
Shabnam Ansari
NGNidhi Gupta
Nidhi Gupta
RVRohit Verma
Rohit Verma
OSOinam N Singh
Oinam N Singh
JGJyoti Gupta
Jyoti Gupta
MSMilan Surjit
Milan Surjit

20 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
ABAkshay Anil Binayke
Akshay Anil Binayke
AZAymaan Zaheer
Aymaan Zaheer
JDJyotsna Dandotiya
Jyotsna Dandotiya
SGSonu Kumar Gupta
Sonu Kumar Gupta
SMShailendra Mani
Shailendra Mani
AAAmit Awasthi
Amit Awasthi
The underlying factors contributing to the evolution of SARS-CoV-2-specific T cell responses during COVID-19 infection remain unidentified. To address this, we characterized innate and adaptive immune responses with metabolomic profiling longitudinally at three different time points (0–3, 7–9, and 14–16 days post-COVID-19 positivity) from young, mildly symptomatic, active COVID-19 patients infected during the first wave in mid-2020. We observed that anti-RBD IgG and viral neutralization are significantly reduced against the delta variant, compared to the ancestral strain. In contrast, compared to the ancestral strain, T cell responses remain preserved against the delta and omicron variants. We determined innate immune responses during the early stage of active infection, in response to TLR 3/7/8-mediated activation in PBMCs and serum metabolomic profiling. Correlation analysis indicated PBMCs-derived proinflammatory cytokines, IL-18, IL-1β, and IL-23, and the abundance of plasma metabolites involved in arginine biosynthesis were predictive of a robust SARS-CoV-2-specific Th1 response at a later stage (two weeks after PCR positivity). These observations may contribute to designing effective vaccines and adjuvants that promote innate immune responses and metabolites to induce a long-lasting anti-SARS-CoV-2-specific T cell response.

12 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAkshay Anil Binayke
Akshay Anil Binayke
AZAymaan Zaheer
Aymaan Zaheer
JDJyotsna Dandotiya
Jyotsna Dandotiya
SGSonu K Gupta
Sonu K Gupta
SMShailendra Mani
Shailendra Mani
AAAmit Awasthi
Amit Awasthi
The underlying factors contributing to the evolution of SARS-CoV-2-specific T cell response during COVID-19 infection remain unidentified. To address this, we characterized innate and adaptive immune responses with metabolomic profiling longitudinally at three different time points (0-4, 7-9, and 14-16 days post-COVID-19 positivity) from young mildly symptomatic active COVID-19 patients who got infected with ancestral virus. We observed the induction of anti-RBD and SARS-CoV-2 neutralizing antibodies together with antigen-specific T cell responses as early as 0-4 days post-infection. T cell responses were largely preserved against the delta and omicron variants as compared to the ancestral strain. We determined innate immune responses at an early (days 0-4 post-COVID-19 positivity) time point of active infection in response to TLR 3/7/8 mediated activation. Interestingly, the innate immune response exhibited by the elevated levels of IL-6, IL-1β, and IL-23 correlated with a robust SARS-CoV-2-specific Th1 response at the later time point (14-16 days post covid positivity). To further understand the association of metabolic pathways induced upon active COVID-19 infection with innate and T cell response, metabolomic profiling was performed. As compared to healthy individuals, COVID-19 patients displayed a distinct metabolic signature with an enrichment of pyroglutamate, itaconate, and azelaic acid, which correlated with the SARS-CoV-2-induced innate and T cells response. Our observations reveal mechanisms and potential interventional approaches that may assist in COVID-19 therapeutics and vaccine adjuvant strategies. One Sentence Summary T cell Immune response against SARS-CoV-2 is driven by a proinflammatory innate immune response and an associated metabolic signature in young adults.